BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 27051285)

  • 41. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
    Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
    Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells.
    González-Fernández B; Sánchez DI; Crespo I; San-Miguel B; Álvarez M; Tuñón MJ; González-Gallego J
    Biofactors; 2017 Mar; 43(2):272-282. PubMed ID: 27801960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis.
    Chatani N; Kamada Y; Kizu T; Ogura S; Furuta K; Egawa M; Hamano M; Ezaki H; Kiso S; Shimono A; Ouchi N; Yoshida Y; Takehara T
    Liver Int; 2015 Aug; 35(8):2017-26. PubMed ID: 25488180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis.
    Hassan R; Tammam SN; Safy SE; Abdel-Halim M; Asimakopoulou A; Weiskirchen R; Mansour S
    Eur J Pharm Biopharm; 2019 Jan; 134():96-106. PubMed ID: 30471341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic value of T2 relaxation time for hepatic iron grading in rat model of fatty and fibrotic liver.
    Jin M; Jiang Y; Zhao Q; Pan Z; Xiao F
    PLoS One; 2022; 17(12):e0278574. PubMed ID: 36469532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.
    Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X
    J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
    Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
    Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.
    Li X; Yao QY; Liu HC; Jin QW; Xu BL; Zhang SC; Tu CT
    J Cell Mol Med; 2017 Oct; 21(10):2370-2385. PubMed ID: 28378526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro.
    Zhang Z; Guo Y; Zhang S; Zhang Y; Wang Y; Ni W; Kong D; Chen W; Zheng S
    Eur J Pharmacol; 2013 Dec; 721(1-3):133-40. PubMed ID: 24076327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. JNK1 and JNK2 regulate α-SMA in hepatic stellate cells during CCl4 -induced fibrosis in the rat liver.
    Hong IH; Park SJ; Goo MJ; Lee HR; Park JK; Ki MR; Kim SH; Lee EM; Kim AY; Jeong KS
    Pathol Int; 2013 Oct; 63(10):483-91. PubMed ID: 24134609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dimethyl α-ketoglutarate reduces CCl
    Zhao J; Peng L; Cui R; Guo X; Yan M
    Biochem Biophys Res Commun; 2016 Dec; 481(1-2):90-96. PubMed ID: 27823933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
    Twu YC; Lee TS; Lin YL; Hsu SM; Wang YH; Liao CY; Wang CK; Liang YC; Liao YJ
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of acupuncture intervention on hepatic platelet-derived growth factor signaling pathway in CCl4-induced hepatic fibrosis rats].
    Kong DS; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Chen WX; Zheng SZ
    Zhen Ci Yan Jiu; 2012 Apr; 37(2):87-92. PubMed ID: 22764591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deferoxamine alleviates liver fibrosis induced by CCl4 in rats.
    Mohammed A; Abd Al Haleem EN; El-Bakly WM; El-Demerdash E
    Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):760-8. PubMed ID: 27168353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis.
    El-Mezayen NS; El-Hadidy WF; El-Refaie WM; Shalaby TI; Khattab MM; El-Khatib AS
    J Control Release; 2017 Nov; 266():226-237. PubMed ID: 28965860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis.
    Kao YH; Lin YC; Tsai MS; Sun CK; Yuan SS; Chang CY; Jawan B; Lee PH
    Biochim Biophys Acta; 2014 Sep; 1842(9):1720-32. PubMed ID: 24970745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
    He J; Bai K; Hong B; Zhang F; Zheng S
    Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Staging Liver Fibrosis: Comparison of Native T1 Mapping, T2 Mapping, and T1ρ: An Experimental Study in Rats With Bile Duct Ligation and Carbon Tetrachloride at 11.7 T MRI.
    Lu Y; Wang Q; Zhang T; Li J; Liu H; Yao D; Hou L; Tu B; Wang D
    J Magn Reson Imaging; 2022 Feb; 55(2):507-517. PubMed ID: 34254388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
    Kim J; Kim E; Euceda LR; Meyer DE; Langseth K; Bathen TF; Moestue SA; Huuse EM
    J Magn Reson Imaging; 2018 Jun; 47(6):1589-1600. PubMed ID: 29205621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study.
    Smits LP; Coolen BF; Panno MD; Runge JH; Nijhof WH; Verheij J; Nieuwdorp M; Stoker J; Beuers UH; Nederveen AJ; Stroes ES
    Radiology; 2016 Mar; 278(3):782-91. PubMed ID: 26348104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.